Diagnostic laboratory Testing
ID: NOI-NIAID-2254740Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIAIDBETHESDA, MD, 20892, USA

NAICS

Testing Laboratories and Services (541380)

PSC

MEDICAL- LABORATORY TESTING (Q301)

Original Source

https://sam.gov/opp/2c0ad6581590427d8d0004295e1cf4ac/view
Timeline
    Description

    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole-source contract with Antech Diagnostics, Inc. for one year of diagnostic laboratory testing services at the NIH Animal Center in Poolesville, Maryland. The required services include clinical pathological evaluations of blood and other bodily fluids from non-human primates, encompassing tests such as Complete Blood Counts, Blood Chemistry Analysis, and Urinalysis, which are critical for ensuring accurate and timely results in research. This procurement is justified under the statutory authority allowing non-competitive procurement due to the necessity for continuity in laboratory services, and interested parties are invited to submit capability statements by January 23, 2023, to Calvin Robinson at calvin.robinson@nih.gov for consideration.

    Point(s) of Contact
    Calvin Robinson
    (406) 363-9214
    calvin.robinson@nih.gov
    Files
    Title
    Posted
    2 - NOI-NIAID.doc
    The National Institute of Allergy and Infectious Diseases (NIAID) is issuing a Pre-Solicitation Notice indicating its intent to negotiate a sole-source contract with Antech Diagnostics, Inc. for one year of diagnostic testing services at the NIH Animal Center in Poolesville, MD. The required services are essential for conducting clinical pathological evaluations of bodily fluids from non-human primates, which includes tests such as Complete Blood Counts and Blood Chemistry Analysis. NIAID seeks to ensure continuity and accuracy in laboratory results, leading to the decision to negotiate with Antech Diagnostics based on the statutory authority allowing non-competitive procurement under specific circumstances. Interested parties that could provide similar services are invited to submit capability statements by January 23rd, 2023. This notice emphasizes the government's discretion in determining the necessity for competitive procurement based on the submissions received.
    Lifecycle
    Title
    Type
    Diagnostic laboratory Testing
    Currently viewing
    Presolicitation
    Similar Opportunities
    Hardy Diagnostic Reagents and Supplies
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a sole-source contract to Hardy Diagnostics for the procurement of culture media and organism supplies necessary for cGMP Sterility Testing Services. The primary objective is to ensure compliance with FDA regulations by utilizing cGMP quality materials that have been rigorously validated, as these supplies are critical for the isolation and identification of pathogens affecting critically ill patients. The contract will cover a base period of twelve months with an option for an additional three months, and interested vendors capable of providing similar products are encouraged to submit capability statements by the specified deadline. For further inquiries, potential respondents may contact Kimala Winfield at kimala.winfield@nih.gov or Malinda Dehner at dehnerm@cc.nih.gov.
    ANTIBODY REAGENT KITS
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking to procure antibody reagent kits from Abcam, Inc. for a technology development project aimed at validating results from mass cytometry panels used to study the human immune system. These antibody kits are crucial for phenotyping the immunome, which is essential for understanding both normal and pathogenic immune responses in various diseases. Interested vendors capable of providing comparable services are invited to submit a capabilities statement via the NIAID electronic Simplified Acquisition Submission System (eSASS) by 9:00 AM EST on January 21, 2025. For further inquiries, vendors may contact Maliaka Pinkney at maliaka.pinkney@nih.gov or Jesse D Weidow at weidowjd@niaid.nih.gov.
    MAINTENANCE AND REPAIR SERVICE AGREEMENT FOR A STELLARIS CONFOCAL SYSTEM
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking to establish a one-year maintenance and repair service agreement for various Leica microscopy equipment. The contract, which will run from March 1, 2025, to February 29, 2026, is intended for the repair and maintenance of specific Leica instruments, including ultramicrotomes and sputter coaters, all of which are critical for advanced laboratory research. As this is a sole source requirement, only Leica Microsystems Inc. or their priority partners are eligible to provide the necessary services, and interested vendors must submit a capability statement demonstrating their qualifications by January 20, 2025. For further inquiries, potential bidders can contact Kelly Lowe at kelly.lowe@nih.gov or by phone at 406-802-6180.
    Sebia Inc. Hydrasys 2 Reagents for the Department of Laboratory Medicine
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to procure Sebia Inc. Hydrasys 2 reagents through a sole-source contract for the Department of Laboratory Medicine. This acquisition aims to secure essential reagent kits, quality control materials, and supplies necessary for electrophoresis testing, which is critical for monitoring patients with B-cell malignancies and central nervous system diseases. The Sebia reagent kits are uniquely designed for compatibility with the existing Sebia Hydrasys 2 analyzers, ensuring high-quality patient care within the Chemistry Service. Interested parties may submit capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by January 31, 2024, at 6:30 AM EST, as this is not a request for quotations.
    NUcleic acid Linked Immuno-Sandwich Assay Reagents
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of NUcleic acid Linked Immuno-Sandwich Assay Reagents, aimed at enhancing biomarker discovery for neurodegenerative disease research at the Center for Alzheimer’s Disease and Related Dementias (CARD). The acquisition includes the Alamar NULISAseq Inflammation Panel, with a requirement for 30 units that must demonstrate high sensitivity in analyzing over 250 proteins from minimal sample volumes, ensuring compatibility with the ARGO proteomics platform. This procurement is critical for advancing research capabilities in the detection of biomarkers related to Alzheimer’s Disease and Related Dementias (ADRD). Interested vendors must submit their quotations by January 22, 2025, at 12:00 PM Eastern Time, to Andrea Clay at amcgee@nida.nih.gov, and must comply with all specified federal regulations and provisions outlined in the solicitation.
    GOLD SERVICE PLAN ANNUAL RENEWAL FOR MICROBETA LUMIJET INSTRUMENTS
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for the annual renewal of the Gold Service Plan for two Microbeta2 Lumijet instruments. This procurement aims to ensure reliable and reproducible data collection through preventive maintenance and repair services for the instruments, which are critical for research in viral gene expression and vaccine development. The awarded contract will cover a 12-month service plan, including one preventive maintenance visit and unlimited repair services, with the submission deadline set for January 22, 2025, at 1:00 PM EST. Interested vendors can contact Angela Puddy at angela.puddy@nih.gov or Tonia Alexander at talexander@niaid.nih.gov for further details.
    Haemonetics Corporation - Preventative Maintenance Agreement
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to award a sole source contract to Haemonetics Corporation for a Preventative Maintenance Agreement concerning two Automated Cell Processors ACP® 215. The contract will cover preventative maintenance services for a base year and three optional one-year periods, ensuring that the equipment operates in compliance with FDA regulations and manufacturer specifications, which is critical for supporting patient care through blood product services. Interested parties capable of providing similar services may submit a capability statement by January 27, 2025, to Emeka Onyejekwe at emeka.onyejekwe@nih.gov for consideration, although the decision to pursue competitive procurement remains at the discretion of the government.
    Brand-Name or Equal, Acquisition of Agilent Bioanalyzer 5200 Fragment analyzer system for ETB Group at NCATS.
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking responses for the acquisition of a Brand-Name or Equal Agilent Bioanalyzer 5200 Fragment Analyzer system for the ETB Group at the National Center for Advancing Translational Sciences (NCATS). The procurement includes the Bioanalyzer system, a computer and monitor, controller and analysis software, capillary array, and installation/familiarization services, which are crucial for nucleic acid quantification and characterization in biomedical research. This advanced equipment is essential for high-throughput separation and quantification of DNA and RNA, supporting NIH's mission to enhance health and reduce illness through innovative medical research. Interested vendors must submit their capability statements by January 27, 2025, at 9 am Eastern Time, to Contract Specialist Giuliana Faller at giuliana.faller@nih.gov.
    Toxicity testing on a new PET ligand (Sources Sought)
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified contractors to conduct a toxicity study on a new PET ligand, Fluorine-18-Fluorocellobiose, as part of the Investigational New Drug (IND) application process. The project entails performing a single-dose toxicity study on Sprague Dawley rats, adhering to FDA's Good Laboratory Practice (GLP) standards, with the aim of assessing toxicity endpoints and developing analytical methods for drug level evaluation. This initiative underscores NIH's commitment to advancing biomedical research while ensuring compliance with regulatory requirements in drug development. Interested parties must submit their responses, including company information and capability statements, to Grace Wong-Darko at Grace.Wong-Darko@nih.gov by 1:00 PM EST on January 31, 2025.
    SPEEDBioSystems TURBO293 Transfection Reagents
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a procurement contract with SPEED BioSystems, LLC for the acquisition of TURBO293 Transfection Reagents. The requirement includes 46 units of the TURBO293 TRANSFECTION REAGENT (20ML), which are critical for ongoing research and development activities at the Vaccine Research Center in Bethesda, Maryland. This procurement is being conducted on a sole-source basis due to SPEED BioSystems, LLC being the sole owner and developer of the required reagents, ensuring continuity and compatibility with existing protocols. Interested vendors may submit their capabilities statements to Jessica Emerson at jessica.emerson@nih.gov by the specified deadline for consideration, although the government is under no obligation to award a contract based on the responses received.